Barclays’s NewAge, Inc. Common Stock (Delaware) NBEV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-971
Closed 5333
2022
Q2
$0 Sell
971
-20,868
-96% -$7.88K ﹤0.01% 5467
2022
Q1
$13K Buy
+21,839
New +$15.6K ﹤0.01% 4561
2020
Q3
Sell
-96,447
Closed -$146K 5740
2020
Q2
$146K Sell
96,447
-121,247
-56% -$181K ﹤0.01% 4293
2020
Q1
$302K Buy
217,694
+121,964
+127% +$219K ﹤0.01% 3995
2019
Q4
$174K Sell
95,730
-53,842
-36% -$127K ﹤0.01% 5138
2019
Q3
$413K Sell
149,572
-9,659
-6% -$34.1K ﹤0.01% 4400
2019
Q2
$742K Sell
159,231
-95,070
-37% -$487K ﹤0.01% 3983
2019
Q1
$1.34M Sell
254,301
-310,478
-55% -$1.87M ﹤0.01% 3076
2018
Q4
$2.94M Buy
+564,779
New +$2.96M ﹤0.01% 2026
2018
Q3
Sell
-2,425
Closed -$5K 7510
2018
Q2
$5K Buy
2,425
+2,377
+4,952% +$4.47K ﹤0.01% 6716
2018
Q1
$0 Sell
48
-114
-70% -$362 ﹤0.01% 7448
2017
Q4
$0 Sell
162
-44
-21% -$104 ﹤0.01% 7205
2017
Q3
$1K Buy
+206
New +$873 ﹤0.01% 6790

Other funds holding NBEV

Barclays's NBEV Position: Q3 2022 in Review

Barclays sold out of NewAge, Inc. Common Stock (Delaware) (NBEV) in Q3 2022, closing a stake of 971 shares.

Barclays first reported a position in NBEV in Q3 2017 and held it in 13 quarters. The position peaked at $2.94M in Q4 2018. 12 funds tracked by Wall St. Rank hold NBEV as of Q3 2022.

  • Barclays reported no remaining NewAge, Inc. Common Stock (Delaware) position as of Q3 2022 after selling out during the quarter.
  • Barclays sold 971 NewAge, Inc. Common Stock (Delaware) shares in Q3 2022.
  • Barclays first reported a position in NewAge, Inc. Common Stock (Delaware) in Q3 2017 and held it in 13 quarters.
  • Barclays's NewAge, Inc. Common Stock (Delaware) position peaked at $2.94M in Q4 2018.
  • 12 funds tracked by Wall St. Rank held NewAge, Inc. Common Stock (Delaware) as of Q3 2022.

Based on Barclays's 13F filing for Q3 2022, filed 3 Nov 2022.